The Bipolar Lithium Imaging Scan Study. - Trial NCT06134349
Access comprehensive clinical trial information for NCT06134349 through Pure Global AI's free database. This phase not specified trial is sponsored by Leiden University Medical Center and is currently Not yet recruiting. The study focuses on Bipolar Disorder. Target enrollment is 80 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Leiden University Medical Center
Timeline & Enrollment
N/A
Jan 01, 2024
Jan 01, 2027
Primary Outcome
Concentration of lithium in the brain, using average whole-brain concentration and concentrations in pre-defined regions of interest (ROI).
Summary
The primary goal of this observational study is to explore to which extent lithium
 concentrations in the brains in BD subjects correlate with clinical treatment response.
 
 Secondary, to determine correlations of brain lithium concentrations with serum lithium
 levels.
 
 Participants will undergo lithium magnetic resonance spectroscopy imaging (MRSI) within two
 weeks of reaching adequate serum lithium level. A blood sample will be drawn to determine
 lithium serum level and after one year a validated questionnaire will be used to assess
 clinical lithium response. Participants start with lithium treatment as part of their regular
 treatment.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06134349
Device Trial